| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3376 | 2020 |
| Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial RD McBane II, WE Wysokinski, JG Le‐Rademacher, T Zemla, A Ashrani, ... Journal of thrombosis and haemostasis 18 (2), 411-421, 2020 | 511 | 2020 |
| Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19 … AC Spyropoulos, M Goldin, D Giannis, W Diab, J Wang, S Khanijo, ... JAMA internal medicine 181 (12), 1612-1620, 2021 | 428 | 2021 |
| Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 403 | 2020 |
| Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant JD Douketis, AC Spyropoulos, J Duncan, M Carrier, G Le Gal, AJ Tafur, ... JAMA internal medicine 179 (11), 1469-1478, 2019 | 379 | 2019 |
| Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and haemostasis 120 (07), 1004-1024, 2020 | 288 | 2020 |
| Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial E Ramacciotti, LB Agati, D Calderaro, VCR Aguiar, AC Spyropoulos, ... The Lancet 399 (10319), 50-59, 2022 | 241 | 2022 |
| Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology … GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628, 2020 | 189 | 2020 |
| Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer AS Mansfield, AJ Tafur, CE Wang, TV Kourelis, EM Wysokinska, P Yang Journal of Thrombosis and Haemostasis 14 (9), 1773-1778, 2016 | 138 | 2016 |
| Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline JD Douketis, AC Spyropoulos, MH Murad, JI Arcelus, WE Dager, AS Dunn, ... Chest 162 (5), e207-e243, 2022 | 126 | 2022 |
| Venous thromboembolism prophylaxis using the Caprini score I Golemi, JPS Adum, A Tafur, J Caprini Disease-a-Month 65 (8), 249-298, 2019 | 122 | 2019 |
| Predictors of major bleeding in peri‐procedural anticoagulation management AJ Tafur, R McBANE II, WE Wysokinski, S Litin, P Daniels, J Slusser, ... Journal of Thrombosis and Haemostasis 10 (2), 261-267, 2012 | 119 | 2012 |
| Utilization of catheter‐directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter‐directed thrombolysis N Patel, NJ Patel, K Agnihotri, SS Panaich, B Thakkar, A Patel, C Savani, ... Catheterization and cardiovascular interventions 86 (7), 1219-1227, 2015 | 102 | 2015 |
| Perioperative management of anticoagulant and antiplatelet therapy A Tafur, J Douketis Heart 104 (17), 1461-1467, 2018 | 80 | 2018 |
| Cancer-associated thrombosis HE Fuentes, AJ Tafur, JA Caprini Disease-a-Month 62 (5), 121-158, 2016 | 79 | 2016 |
| Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 77 | 2020 |
| Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations … AC Spyropoulos, K Brohi, J Caprini, CM Samama, D Siegal, A Tafur, ... Journal of Thrombosis and Haemostasis 17 (11), 1966-1972, 2019 | 77 | 2019 |
| Acquired and congenital risk factors associated with cerebral venous sinus thrombosis RD McBane II, A Tafur, WE Wysokinski Thrombosis research 126 (2), 81-87, 2010 | 76 | 2010 |
| The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) study for patients on a direct oral anticoagulant who need an elective surgery or procedure: design and rationale JD Douketis, AC Spyropoulos, JM Anderson, DM Arnold, SM Bates, ... Thrombosis and haemostasis 117 (12), 2415-2424, 2017 | 75 | 2017 |
| Comparisons between upper and lower extremity deep vein thrombosis: a review of the RIETE registry LP Cote, S Greenberg, JA Caprini, A Tafur, C Choi, FJ Muñoz, A Skride, ... Clinical and Applied Thrombosis/Hemostasis 23 (7), 748-754, 2017 | 71 | 2017 |
HARRY E FUENTESMayo Clinic在 mayo.edu 的电子邮件经过验证
